Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $764.9800 (2.29%) ($764.9800 - $764.9800) on Wed. Dec. 7, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.84% (three month average) | RSI | 63 | Latest Price | $764.9800(2.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.4% a day on average for past five trading days. | Weekly Trend | REGN advances 1.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) DIA(33%) SPLV(30%) IWD(29%) IVW(28%) | Factors Impacting REGN price | REGN will decline at least -1.42% in a week (0% probabilities). TBT(-16%) URA(-3%) ARKG(-2%) VCSH(-1%) UUP(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.42% (StdDev 2.84%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $758.64(0.84%) | 10 Day Moving Average | $749.8(2.02%) | 20 Day Moving Average | $744.7(2.72%) | To recent high | -0.1% | To recent low | 28.3% | Market Cap | $81.11b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |